BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • BCI
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Saturday, July 11, 2026
Home » Authors » Douglas Merrill

Articles by Douglas Merrill

Biotech Investing Strategies Shift To Deal With Bear Market

Nov. 13, 2002
By Douglas Merrill

Partnering Discussions Supplant Market Difficulties In Stuttgart

Nov. 13, 2002
By Douglas Merrill

Pieris Raises EUR12M To Fund Programs In Protein Engineering

Nov. 6, 2002
By Douglas Merrill

German Government Reducing Support For Start-Up Companies

Nov. 6, 2002
By Douglas Merrill
MUNICH, Germany - German Chancellor Gerhard Schroeder formally laid out his government's plans for its second term in a speech last week to the Bundestag, the country's parliament, which stressed the need for savings in difficult economic times. While the speech did not mention biotechnology specifically, the re-elected government's plans have two significant elements for the sector. (BioWorld International)
Read More

Pieris Raises EUR12M To Fund Programs In Protein Engineering

Nov. 6, 2002
By Douglas Merrill

German Government Reducing Support For Start-Up Companies

Nov. 6, 2002
By Douglas Merrill
MUNICH, Germany - German Chancellor Gerhard Schroeder formally laid out his government's plans for its second term in a speech last week to the Bundestag, the country's parliament, which stressed the need for savings in difficult economic times. While the speech did not mention biotechnology specifically, the re-elected government's plans have two significant elements for the sector. (BioWorld International)
Read More

Sireen Raises EUR5M Privately To Advance Discovery Program

Oct. 30, 2002
By Douglas Merrill

Sireen Raises EUR5M Privately To Advance Discovery Program

Oct. 30, 2002
By Douglas Merrill

MediGene Joins With Evotec On Cardiology Discovery Unit

Oct. 16, 2002
By Douglas Merrill

MediGene Joins With Evotec On Cardiology Discovery Unit

Oct. 16, 2002
By Douglas Merrill
Previous 1 2 … 17 18 19 20 21 22 23 24 25 26 27 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for July 10, 2026.
  • 3D rendering of an antibody drug conjugate

    ‘Target-high but uptake-defective’ state identified in ADC resistance

    BioWorld
    Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
  • Wainua autoinjector

    Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy

    BioWorld
    News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
  • Art concept for medical research

    FENS 2026: Shedding light on the sheddome

    BioWorld
    At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
  • Silhouette with keyhole

    FENS 2026: Next-gen biologics take on brain disease

    BioWorld
    Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing